Gene · 9757
Papers2,805
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,805
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nanopore long-read sequencing facilitates accurate diagnosis of KMT2B-related dystonia. | Clin Epigenetics | 2026 | 42754922 | PubTator, text mining | PubMed |
| [Genetic Dystonias]. | Medicina (B Aires) | 2026 | 42659549 | PubTator, text mining | PubMed |
| Chromatin condensates tune nuclear mechanosensing and preserve nuclear integrity to prevent cGAS activation. | EMBO J | 2026 | 42587091 | PubTator, text mining | PubMed |
| BAP1 and UTX are dispensable for transcription-driven Polycomb erasure but essential for enhancer establishment. | J Biol Chem | 2026 | 42567521 | PubTator, text mining | PubMed |
| Rare-Variant Burden Analysis of Dystonia Genes in Parkinson's Disease. | Mov Disord | 2026 | 42541459 | PubTator, text mining | PubMed |
| Correction: Central precocious puberty as the initial manifestation of multisystem involvement caused by de novo heterozygous KMT2B mutation and STS hemizygous deletion: a case report. | Front Endocrinol (Lausanne) | 2026 | 42488006 | PubTator, text mining | PubMed |
| Genetic analysis of childhood-onset dystonia-28 caused by a variant (c.5076G>A) in the KMT2B gene. | Glob Med Genet | 2026 | 42440406 | PubTator, text mining | PubMed |
| Central precocious puberty as the initial manifestation of multisystem involvement caused by de novo heterozygous KMT2B mutation and STS hemizygous deletion: a case report. | Front Endocrinol (Lausanne) | 2026 | 42388856 | PubTator, text mining | PubMed |
| Prohibitins in cancer: Multifaceted regulators of mitochondrial homeostasis, oncogenic signaling, tumor microenvironment, and therapeutic resistance. | Cancer Genet | 2026 | 42341379 | PubTator, text mining | PubMed |
| Diagnostic value of genetic testing in chorea: a retrospective monocentric study. | J Neurol | 2026 | 42321428 | PubTator, text mining | PubMed |
| KMT2A and KMT2B episignatures address diagnostic challenges associated with rare neurodevelopmental disorders. | Genet Med | 2026 | 42318777 | PubTator, text mining | PubMed |
| Brain metastatic paraganglioma from liver: a case report and review of the literature. | J Med Case Rep | 2026 | 42316325 | PubTator, text mining | PubMed |
| The genetic landscape of childhood-onset dystonia in a nationwide Turkish cohort: Clinical spectrum, molecular diagnostics, and therapeutic implications. | Eur J Paediatr Neurol | 2026 | 42308683 | PubTator, text mining | PubMed |
| Molecular mechanisms of the MLL4 complex in H3K4 methylation and p53-dependent transcription activation. | Mol Cell | 2026 | 42214331 | PubTator, text mining | PubMed |
| Clinical Phenotype Comparison in Polish Patient Cohorts with and Without Molecular Diagnosis of Dystonia. | J Clin Med | 2026 | 42194935 | PubTator, text mining | PubMed |
| MLL3 and MLL4 sustain hematopoietic stem cell multipotency by opposing a B-cell default state. | Blood | 2026 | 42118696 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of vulvar squamous cell carcinoma reveals subtype-specific mutational landscapes. | Virchows Arch | 2026 | 42113264 | PubTator, text mining | PubMed |
| Single-cell transcriptomic profiling of colorectal cancer brain metastasis. | Discov Oncol | 2026 | 42090027 | PubTator, text mining | PubMed |
| KMT2B induces the H3K4 trimethylation of RBBP6 promoter to enhance the 131I sensitivity in thyroid carcinoma by restraining STAT1/DPP4 axis. | Epigenomics | 2026 | 42011633 | PubTator, text mining | PubMed |
| Clinical, imaging and genetic profile of KMT2B-related dystonia: a review of published cases. | J Neural Transm (Vienna) | 2026 | 41925783 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9757/papers